417 related articles for article (PubMed ID: 11426497)
1. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
Takemori N; Kondo K; Kawamura T; Imai K; Sakurai H; Sato T
Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
[TBL] [Abstract][Full Text] [Related]
2. [Multiple myeloma of the IgD-lambda type invading CNS].
Kitamura K; Takeuchi J; Kanbe E; Oka H; Saiki M; Aikawa S; Kura Y; Hatta Y; Yamazaki T; Ito T; Sawada U; Horie T
Rinsho Ketsueki; 2004 Oct; 45(10):1124-8. PubMed ID: 15553049
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma].
Takagi T; Oguro M; Sakai C
Rinsho Ketsueki; 1986 Dec; 27(12):2249-53. PubMed ID: 3471977
[No Abstract] [Full Text] [Related]
4. [Combination chemotherapy of multiple myeloma].
Uzuka Y; Saito Y; Ito T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1481-7. PubMed ID: 2389944
[TBL] [Abstract][Full Text] [Related]
5. Oligoclonal reconstitution masquerading as myeloma relapse.
Chim CS; Chan EY
Ann Hematol; 2013 Jun; 92(6):847-8. PubMed ID: 23150202
[No Abstract] [Full Text] [Related]
6. [Combination chemotherapy of MCNU, melphalan, procarbazine, and prednisolone (MMPP) in multiple myeloma; disappearance of M-peak on serum electrophoretic pattern].
Kamiya O; Hoshino A; Ohara K; Nagata K; Ono Y; Saito M; Itou T; Yamamoto K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):863-5. PubMed ID: 2469398
[No Abstract] [Full Text] [Related]
7. [IgD myeloma: an aggressive variant. Description of a clinical case and review of the literature].
Airoldi M; Pelucco L; Lamperti R; Gioia F
Recenti Prog Med; 1993 Jun; 84(6):423-7. PubMed ID: 8516549
[TBL] [Abstract][Full Text] [Related]
8. [Recent therapy for refractory myeloma].
Togawa A
Rinsho Ketsueki; 1993 Apr; 34(4):450-4. PubMed ID: 8510332
[TBL] [Abstract][Full Text] [Related]
9. Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
Witzens-Harig M; Waldherr R; Beimler J; Zeier M; Hansmann J; Ho AD; Goldschmidt H; Moehler T
Ann Hematol; 2007 Dec; 86(12):927-30. PubMed ID: 17605010
[No Abstract] [Full Text] [Related]
10. Long-term complete remission in IgD-myeloma.
Bemelmans RH; van Toorn DW; van Leeuwen L; Schaar CG
Eur J Haematol; 2006 Apr; 76(4):339-41. PubMed ID: 16519706
[TBL] [Abstract][Full Text] [Related]
11. [Four cases of therapy-related leukemia in multiple myeloma].
Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
[TBL] [Abstract][Full Text] [Related]
12. VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
McElwain TJ; Gore ME; Meldrum M; Viner C; Judson IR; Malpas JS
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():109-12. PubMed ID: 2697419
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide for the treatment of leptomeningeal multiple myeloma.
Yutaka H; Mariko Y; Shinichiro O; Kunihiko M; Yusuke T; Yasuo I
Eur J Haematol; 2006 Apr; 76(4):358-9. PubMed ID: 16519710
[No Abstract] [Full Text] [Related]
14. [Comparative studies of intermittent melphalan and prednisolone (MP) versus 5-drug regimen (QUVMP) and 3-drug regimen (QUP) in multiple myeloma].
Hoshino S; Saito H; Wada M; Akutsu M; Shiozaki H; Takanashi M; Takei Y; Tanaka S; Teramura M; Takada K
Rinsho Ketsueki; 1987 Mar; 28(3):358-65. PubMed ID: 3475485
[No Abstract] [Full Text] [Related]
15. [Chemotherapy of multiple myeloma].
Golenkov AK
Sov Med; 1991; (3):43-6. PubMed ID: 1882290
[No Abstract] [Full Text] [Related]
16. [Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy].
Uzuka Y; Saito Y; Takahashi H; Komatsu M; Ito T
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2269-73. PubMed ID: 2735769
[TBL] [Abstract][Full Text] [Related]
17. [Study on the therapy of multiple myelomas--initial induction therapy (MP, IFN alpha, steroid pulse) and maintenance therapy (VMP, MP continuous, VEP, MCNU)].
Tanaka H; Kawano M; Iwato K; Asaoku H; Tanabe O; Ishikawa H; Nobuyoshi M; Sakai A; Kuramoto A
Rinsho Ketsueki; 1992 May; 33(5):655-61. PubMed ID: 1630017
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma: the National University Hospital (NUH) experience.
Lim HL; Teo CP; Wong K; Kuperan P; Suri R; Tan YO; Kueh YK
Singapore Med J; 1994 Aug; 35(4):371-3. PubMed ID: 7899894
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy of polychemotherapy programs in treating multiple myeloma patients].
Bessmel'tsev SS; Abdulkadyrov KM; Rukavitsyn OA
Ter Arkh; 1998; 70(7):46-9. PubMed ID: 9742636
[TBL] [Abstract][Full Text] [Related]
20. Refractory multiple myeloma treated with homoharringtonine: report of two cases.
Yang X; Yang C; Shao K; Ye X; Meng H; Zhou Y; Qian W
Ann Hematol; 2007 Dec; 86(12):919-21. PubMed ID: 17641891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
